Dept. of Medical Science/박사Special AT-rich sequence binding protein 1 (SATB1) is a nuclear protein that functions as a global chromatin organizer, regulating chromatin structure and gene expression. Recently, it has been reported that SATB1 is highly expressed in metastatic breast cancer cells and promotes growth and metastasis by reprogramming transcription profiles, suggesting SATB1 as a potential prognostic marker and therapeutic target for metastatic breast cancer. Although SATB1 is known to regulate hundreds of genes, it’s binding to endogenous genes and regulation mechanism have rarely been demonstrated. In this study, we performed a systematic, genome-wide analysis of the functional significance of SATB1 in breast cancer cells. With ...
Background/Aims: Several researches have evaluated the significance of SATB1 (Special AT-rich sequen...
IntroductionLung cancer is the leading cause of cancer-related mortality and requires more effective...
Disease aggressiveness remains a critical factor to the progression of prostate cancer. Transformati...
Special AT-rich sequence binding protein 1 (SATB1) is a nuclear matrix-associated DNA-binding protei...
Global changes in gene expression occur during tumor progression, as indicated by expression profili...
noWhen cells change functions or activities (such as during differentiation, response to extracellul...
Special AT-rich sequence-binding protein-1 (SATB1) has been identified as a genome organizer that re...
Special AT-rich sequence-binding protein-1 (SATB1) has been identified as a genome organizer that re...
Background SATB1 is a nuclear protein that has been recently reported to be a 'genome organizer' wh...
<div><p>Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expres...
© 2018 The Special AT-rich Sequence Binding Protein 1 (SATB1) is a chromatin organiser and transcrip...
Copyright © 2013 Akueni L. Davelaar et al. This is an open access article distributed under the Crea...
Special AT-rich sequence-binding protein 1 (SATB1) is a nuclear matrix protein with a central role i...
Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expressed in v...
Background: The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been rep...
Background/Aims: Several researches have evaluated the significance of SATB1 (Special AT-rich sequen...
IntroductionLung cancer is the leading cause of cancer-related mortality and requires more effective...
Disease aggressiveness remains a critical factor to the progression of prostate cancer. Transformati...
Special AT-rich sequence binding protein 1 (SATB1) is a nuclear matrix-associated DNA-binding protei...
Global changes in gene expression occur during tumor progression, as indicated by expression profili...
noWhen cells change functions or activities (such as during differentiation, response to extracellul...
Special AT-rich sequence-binding protein-1 (SATB1) has been identified as a genome organizer that re...
Special AT-rich sequence-binding protein-1 (SATB1) has been identified as a genome organizer that re...
Background SATB1 is a nuclear protein that has been recently reported to be a 'genome organizer' wh...
<div><p>Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expres...
© 2018 The Special AT-rich Sequence Binding Protein 1 (SATB1) is a chromatin organiser and transcrip...
Copyright © 2013 Akueni L. Davelaar et al. This is an open access article distributed under the Crea...
Special AT-rich sequence-binding protein 1 (SATB1) is a nuclear matrix protein with a central role i...
Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expressed in v...
Background: The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been rep...
Background/Aims: Several researches have evaluated the significance of SATB1 (Special AT-rich sequen...
IntroductionLung cancer is the leading cause of cancer-related mortality and requires more effective...
Disease aggressiveness remains a critical factor to the progression of prostate cancer. Transformati...